Cancer vaccines in the clinic
Vaccines are an important tool in the rapidly evolving repertoire of immunotherapies in
oncology. Although cancer vaccines have been investigated for over 30 years, very few …
oncology. Although cancer vaccines have been investigated for over 30 years, very few …
Activation of STING in the pancreatic tumor microenvironment: a novel therapeutic opportunity
Pancreatic ductal adenocarcinoma (PDAC) is a cancer of poor prognosis that presents with
a dense desmoplastic stroma that contributes to therapeutic failure. PDAC patients are …
a dense desmoplastic stroma that contributes to therapeutic failure. PDAC patients are …
Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid tumors with a high
mortality rate and poor survival rate. Depending on the tumor stage, PDAC is either treated …
mortality rate and poor survival rate. Depending on the tumor stage, PDAC is either treated …
Challenges and future perspectives of immunotherapy in pancreatic cancer
Simple Summary Immunotherapeutic agents harness the patient's immune system to fight
cancer cells. Especially immune checkpoint inhibitors, a certain group of immunotherapeutic …
cancer cells. Especially immune checkpoint inhibitors, a certain group of immunotherapeutic …
Recent advances and future perspective of DC-based therapy in NSCLC
IAE van der Hoorn, G Flórez-Grau… - Frontiers in …, 2021 - frontiersin.org
Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since
therapy is only effective in a minority of patients and does not always induce a long-lasting …
therapy is only effective in a minority of patients and does not always induce a long-lasting …
Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development
N Gautam, G Ramamoorthi, N Champion… - Molecular Aspects of …, 2024 - Elsevier
Breast cancer is a heterogeneous disease and is the most prevalent cancer in women.
According to the US breast cancer statistics, about 1 in every 8 women develop an invasive …
According to the US breast cancer statistics, about 1 in every 8 women develop an invasive …
[PDF][PDF] Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer—a narrative review
Key Content and Findings: IRE ablation destructs tumor structure while preserving
extracellular matrix and blood vessels facilitating local inflammation. The studies …
extracellular matrix and blood vessels facilitating local inflammation. The studies …
Research Progress on Liposome Pulmonary Delivery of Mycobacterium tuberculosis Nucleic Acid Vaccine and Its Mechanism of Action
D Zhang, H Zhao, P Li, X Wu, Y Liang - Journal of Aerosol Medicine …, 2024 - liebertpub.com
Traditional vaccines have played an important role in the prevention and treatment of
infectious diseases, but they still have problems such as low immunogenicity, poor stability …
infectious diseases, but they still have problems such as low immunogenicity, poor stability …
[PDF][PDF] 胰腺导管腺癌的免疫治疗研究进展
W Puxiongzhi, YU Xinzhe, SHI Xiangjun, Y Zhou - 中国普通外科杂志, 2021 - zpwz.net
摘要胰腺导管腺癌(PDAC) 是常见的消化系统恶性肿瘤, 恶性程度高, 容易发生转移,
手术切除率低. 近年来, 以程序性细胞死亡蛋白1/程序性死亡配体1 (PD-1/PD-L1) …
手术切除率低. 近年来, 以程序性细胞死亡蛋白1/程序性死亡配体1 (PD-1/PD-L1) …